Literature DB >> 4267531

Continuous intravenous infusions of 5-fluoro-2'-deoxyuridine in the treatment of solid tumors.

R C DeConti, S R Kaplan, R J Papac, P Calabresi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4267531     DOI： 10.1002/1097-0142(197304)31:4<894::aid-cncr2820310420>3.0.co;2-k

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  12 in total

Review 1.  A giant step forward: chimeric antigen receptor T-cell therapy for lymphoma.

Authors:  Houli Zhao; Yiyun Wang; Elaine Tan Su Yin; Kui Zhao; Yongxian Hu; He Huang
Journal:  Front Med       Date:  2020-12-01       Impact factor: 4.592

Review 2.  Are chimeric antigen receptor T cells (CAR-T cells) the future in immunotherapy for autoimmune diseases?

Authors:  Yeison Santamaria-Alza; Gloria Vasquez
Journal:  Inflamm Res       Date:  2021-05-20       Impact factor: 4.575

Review 3.  Monitoring minimal/measurable residual disease in B-cell acute lymphoblastic leukemia by flow cytometry during targeted therapy.

Authors:  Zhiyu Liu; Yang Li; Ce Shi
Journal:  Int J Hematol       Date:  2021-01-27       Impact factor: 2.490

4.  Comparison of reduced-intensity conditioning regimens in patients with acute lymphoblastic leukemia >45 years undergoing allogeneic stem cell transplantation-a retrospective study by the Acute Leukemia Working Party of EBMT.

Authors:  Zinaida Peric; Myriam Labopin; Christophe Peczynski; Emmanuelle Polge; Jan Cornelissen; Ben Carpenter; Mike Potter; Ram Malladi; Jenny Byrne; Harry Schouten; Nathalie Fegueux; Gerard Socié; Montserrat Rovira; Jurgen Kuball; Maria Gilleece; Sebastian Giebel; Arnon Nagler; Mohamad Mohty
Journal:  Bone Marrow Transplant       Date:  2020-05-02       Impact factor: 5.483

Review 5.  Chimeric antigen receptor therapy in hematological malignancies: antigenic targets and their clinical research progress.

Authors:  Juanjuan Zhao; Meirong Wu; Zhifeng Li; Sheng Su; Yin Wen; Litian Zhang; Yuhua Li
Journal:  Ann Hematol       Date:  2020-05-09       Impact factor: 3.673

6.  Randomized assessment of delayed intensification and two methods for parenteral methotrexate delivery in childhood B-ALL: Children's Oncology Group Studies P9904 and P9905.

Authors:  Naomi Winick; Paul L Martin; Meenakshi Devidas; Jonathan Shuster; Michael J Borowitz; W Paul Bowman; Eric Larsen; Jeanette Pullen; Andrew Carroll; Cheryl Willman; Stephen P Hunger; William L Carroll; Bruce M Camitta
Journal:  Leukemia       Date:  2019-11-14       Impact factor: 11.528

Review 7.  Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors.

Authors:  Tatsuki Ueda; Shin Kaneko
Journal:  Int J Hematol       Date:  2020-07-23       Impact factor: 2.490

8.  Antitumor activity of 3',5'-diesters of 5-fluoro-2'-deoxyuridine against murine leukemia L1210 cells.

Authors:  F Kanzawa; A Hoshi; K Kuretani; M Saneyoshi; T Kawaguchi
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

Review 9.  Next-generation CAR T cells to overcome current drawbacks.

Authors:  Stefan Lundh; Sayantan Maji; J Joseph Melenhorst
Journal:  Int J Hematol       Date:  2020-06-27       Impact factor: 2.490

10.  Transformation of diffuse large B cell lymphoma into dendritic sarcoma under CAR T cell therapy detected on 18F-FDG PET/CT.

Authors:  Michael Winkelmann; Kai Rejeski; Marcus Unterrainer; Christian Schmidt; Michael Ruzicka; Jens Ricke; Martina Rudelius; Marion Subklewe; Wolfgang G Kunz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-08-19       Impact factor: 9.236
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.